Inventor · disambiguated record
Hua Cheng
Also filed as: CHENG HUA · CHENG HUA-JEN
13 granted patents·4 pending applications·514 citations·filing 1998–2024
94Inventor score
Files withINTRA CELLULAR THERAPIES INC8TOMESCH JOHN CHARLES2ADAMA MAKHTESHIM LTD1CELARTICS BIOPHARMA CO LTD1UNITED MICROELECTRONICS CORP1
Top patents by PatentIndex Score
17 records- 0198US10464938B2Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 5, 2019·33 cites·12 claims
- 0298US9751883B2Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2016·Granted Sep 5, 2017·86 cites·28 claims
- 0398US9315504B2Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereofINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Apr 19, 2016·88 cites·5 claims
- 0497US11066407B2Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jul 20, 2021·14 cites·10 claims
- 0597US10597395B2Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 24, 2020·23 cites·19 claims
- 0697US10221176B2Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Mar 5, 2019·28 cites·29 claims
- 0797US8779139B2Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereofTOMESCH JOHN CHARLES·Filed 2012·Granted Jul 15, 2014·108 cites·15 claims
- 0897US8309722B2Substituted heterocycle gamma-carbolines synthesisTOMESCH JOHN CHARLES·Filed 2008·Granted Nov 13, 2012·117 cites·44 claims
- 0991US2025101022A1PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONEINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 1083US12139490B2Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-oneINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Nov 12, 2024·0 cites·18 claims
- 1158US2023053477A1Insecticidal MixturesADAMA MAKHTESHIM LTD·Filed 2020·Application pending·0 cites
- 1252US6261861B1Processing flow of a complementary metal-oxide semiconductor color filterUNITED MICROELECTRONICS CORP·Filed 1998·Granted Jul 17, 2001·17 cites·23 claims
- 1351US2021371823A1Method for expanding human dc cell and human dc cell resource libraryCELARTICS BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1448US12098387B2Methods for generating engineered human primary blood dendritic cell linesUNIV MARYLAND·Filed 2016·Granted Sep 24, 2024·0 cites·15 claims
- 1542US2006099482A1Fuel cell electrodeUNIV NEWCASTLE VENTURES LTD·Filed 2003·Application pending·0 cites
- 1641US11166462B2Fungicidal compound, fungicide composition and preparation and use thereofZHEJIANG UDRAGON BIOSCIENCE CO LTD·Filed 2016·Granted Nov 9, 2021·0 cites·14 claims
- 1731US11480050B2Device and method for measuring flow velocity and flow direction and geological parameters of groundwater through cross holes of deep wellsUNIV ANHUI SCI & TECHNOLOGY·Filed 2019·Granted Oct 25, 2022·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Hua Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →